| Oct 31 |
Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024
|
| Oct 21 |
Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024
|
| Oct 17 |
Seer to Report Third Quarter 2024 Financial Results on November 6, 2024
|
| Oct 9 |
Seer Inc (SEER) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges Amid Strategic ...
|
| Sep 26 |
Seer, Inc. (NASDAQ:SEER) has caught the attention of institutional investors who hold a sizeable 50% stake
|
| Aug 22 |
Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
|
| Aug 16 |
Seer, Inc. (NASDAQ:SEER) Analysts Just Slashed This Year's Revenue Estimates By 18%
|
| Aug 14 |
Seer Appoints Nicolas Roelofs to its Board of Directors
|
| Aug 11 |
US$7.00: That's What Analysts Think Seer, Inc. (NASDAQ:SEER) Is Worth After Its Latest Results
|
| Aug 9 |
Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference
|
